Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies

被引:1
作者
Wang, Minkun [1 ,2 ]
Tsai, Tsung-Heng [1 ]
Di Poto, Cristina [1 ]
Ferrarini, Alessia [1 ]
Yu, Guoqiang [2 ]
Ressom, Habtom W. [1 ]
机构
[1] Georgetown Univ, Dept Oncol, 4000 Reservoir Rd NW, Washington, DC 20057 USA
[2] Virginia Tech, Dept Elect & Comp Engn, 900 N Glebe Rd, Arlington, VA USA
来源
BMC GENOMICS | 2016年 / 17卷
关键词
Bayesian inference; Topic model; Purification; LC-MS; GC-MS; Extracted ion chromatogram; Metabolomics; Proteomics; Biomarker discovery; IDENTIFICATION; PROTEOMICS; PROFILES;
D O I
10.1186/s12864-016-2796-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: A fundamental challenge in quantitation of biomolecules for cancer biomarker discovery is owing to the heterogeneous nature of human biospecimens. Although this issue has been a subject of discussion in cancer genomic studies, it has not yet been rigorously investigated in mass spectrometry based proteomic and metabolomic studies. Purification of mass spectometric data is highly desired prior to subsequent analysis, e.g., quantitative comparison of the abundance of biomolecules in biological samples. Methods: We investigated topic models to computationally analyze mass spectrometric data considering both integrated peak intensities and scan-level features, i.e., extracted ion chromatograms (EICs). Probabilistic generative models enable flexible representation in data structure and infer sample-specific pure resources. Scan-level modeling helps alleviate information loss during data preprocessing. We evaluated the capability of the proposed models in capturing mixture proportions of contaminants and cancer profiles on LC-MS based serum proteomic and GC-MS based tissue metabolomic datasets acquired from patients with hepatocellular carcinoma (HCC) and liver cirrhosis as well as synthetic data we generated based on the serum proteomic data. Results: The results we obtained by analysis of the synthetic data demonstrated that both intensity-level and scan-level purification models can accurately infer the mixture proportions and the underlying true cancerous sources with small average error ratios (< 7 %) between estimation and ground truth. By applying the topic model-based purification to mass spectrometric data, we found more proteins and metabolites with significant changes between HCC cases and cirrhotic controls. Candidate biomarkers selected after purification yielded biologically meaningful pathway analysis results and improved disease discrimination power in terms of the area under ROC curve compared to the results found prior to purification. Conclusions: We investigated topic model-based inference methods to computationally address the heterogeneity issue in samples analyzed by LC/GC-MS. We observed that incorporation of scan-level features have the potential to lead to more accurate purification results by alleviating the loss in information as a result of integrating peaks. We believe cancer biomarker discovery studies that use mass spectrometric analysis of human biospecimens can greatly benefit from topic model-based purification of the data prior to statistical and pathway analyses.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Protein Array-based Approaches for Biomarker Discovery in Cancer
    Huang, Yi
    Zhu, Heng
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2017, 15 (02) : 73 - 81
  • [22] Monoisotopic silver nanoparticles-based mass spectrometry imaging of human bladder cancer tissue: Biomarker discovery
    Ossolinski, Krzysztof
    Ruman, Tomasz
    Ossolinski, Tadeusz
    Ossolinska, Anna
    Arendowski, Adrian
    Kolodziej, Artur
    Plaza-Altamer, Aneta
    Niziol, Joanna
    ADVANCES IN MEDICAL SCIENCES, 2023, 68 (01): : 38 - 45
  • [23] Mass Spectrometry-based Quantitative Analysis and Biomarker Discovery
    Suzuki, Naoto
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (09): : 1305 - 1309
  • [24] Mass spectrometry based proteomics in urine biomarker discovery
    Theodorescu, Dan
    Mischak, Harald
    WORLD JOURNAL OF UROLOGY, 2007, 25 (05) : 435 - 443
  • [25] Mass spectrometry based proteomics in urine biomarker discovery
    Dan Theodorescu
    Harald Mischak
    World Journal of Urology, 2007, 25 : 435 - 443
  • [26] Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery
    Liu, Huan
    Zhang, Ningbo
    Wan, Debin
    Cui, Meng
    Liu, Zhiqiang
    Liu, Shuying
    CLINICAL PROTEOMICS, 2014, 11
  • [27] Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery
    Doud, Emma H.
    Yeh, Elizabeth S.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [28] Managing of Unassigned Mass Spectrometric Data by Neural Network for Cancer Phenotypes Classification
    Petrovsky, Denis V.
    Kopylov, Arthur T.
    Rudnev, Vladimir R.
    Stepanov, Alexander A.
    Kulikova, Liudmila I.
    Malsagova, Kristina A.
    Kaysheva, Anna L.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [29] Analysis of premalignant pancreatic cancer mass spectrometry data for biomarker selection using a group search optimizer
    He, S.
    Cooper, H. J.
    Ward, D. G.
    Yao, X.
    Heath, J. K.
    TRANSACTIONS OF THE INSTITUTE OF MEASUREMENT AND CONTROL, 2012, 34 (06) : 668 - 676
  • [30] Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery
    Aristoteli, Lina P.
    Molloy, Mark P.
    Baker, Mark S.
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (02) : 571 - 581